Elon Musk's brain chip startup Neuralink has reportedly received interest from thousands of potential patients

Elon Musk's brain chip startup Neuralink has reportedly received interest from thousands of potential patients, per BI.

Numerous individuals are reportedly expressing interest in becoming recipients of one of Neuralink's initial brain chips.

Founded by Elon Musk in 2016, Neuralink focuses on developing a brain-computer interface capable of enabling diverse applications, ranging from telepathic communication to mind-controlled gaming.

Before realizing broader applications, Neuralink aims to assist individuals with severe neurological disorders by enabling device control and communication through brain activity alone. Having obtained approval from the US Food and Drug Administration in May, Neuralink initiated the application process for human trials in September, seeking participants with quadriplegia or amyotrophic lateral sclerosis.

The response has been substantial, with thousands expressing willingness to undergo the brain-implant procedure, as reported by Bloomberg this week. While Neuralink has not yet conducted human brain-implant surgeries, insights into the process have been gleaned from the startup's videos and media reports.

The device replaces the portion of skull that the surgeon had removed.

Musk has said he wants the surgery to take less time and wants the company to eventually be able to perform the entire surgery without human intervention, Bloomberg reported.

Neuralink has reportedly done more than 150 implantation surgeries.

tastytrade logo+
Get the best broker for options trading and earn Unusual Whales discounted! in cash with an eligible account deposit at tastytrade. Get an Unusual Whales bonus when you deposit $2000. Offer expires 3/31/25. Certain restrictions, terms and conditions apply.
Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.